NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fauna Bio

Fauna Bio

Private
Emeryville, CaliforniaHealthcare & Life Scienceshttps://www.faunabio.com/

Last Round

Series A

Mar 14, 2025

Est. Valuation

$26.31M

Total Funding Raised

$13.7M

Company Overview

Fauna Bio is a biotechnology company that has developed a cross-mammal drug discovery platform to identify novel therapeutics for human diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoverycomparative genomicsAI drug discoverymulti-omicstherapeutic target identificationbiotech platformcomputational biologyin silico drug discoverymetabolic disease researchfibrosis researchcardiovascular disease researchAI-native biotechpreclinical developmentdrug discovery partnershiptarget validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fauna Bio Comparables

Compare Fauna Bio with similar companies based on industry and business-model similarity.

Fauna Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Paratus Sciences
82%
Variant Bio
81%
Gero
78%

Fauna Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 14, 2025
StrategicDec 21, 2023
SeedSep 21, 2021
GrantMar 4, 2021
GrantOct 9, 2019
Seed
Apr 11, 2019

Key People

Founding team and executive leadership

Ashley Zehnder

Co-founder And CEO

Founding Team

Linda Goodman

Chief Technology Officer

Executive Team

Michael F. Geremia

CFO

Executive Team

Fauna Bio Investors

Notable investors and investment history

Fauna Bio investors
InvestorRounds
Pacific 8 VenturesSeed
NIH RADxGrant
age1Seed
Boom CapitalSeed
Lifeforce CapitalSeed
Beagle VenturesSeed
Longevity FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 16, 2025

    Attended BIO International Convention and introduced a new product.

  • Jun 16, 2025

    Introduced a new therapy delivery product at BIO International Convention.

Fauna Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fauna Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fauna Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersEmeryville, California
Employee Range21
Year Founded2018
Last FundingMar 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.